MedTrace Logo

Community Engagement for Early Recognition and Immediate Action in Stroke

NCT02301299 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1322

Last updated 2019-09-09

Study results available
· View outcomes & findings →

Summary

The investigators plan to develop and adapt a community-partnered intervention using community health promoters ("Stroke Promoters") to deliver messaging regarding stroke symptom awareness and the need for calling 911 after stroke onset. The study investigators will implement this intervention in south side Chicago communities and measure the impact on symptom onset to hospital arrival times and EMS utilization using an interrupted time-series analysis.

Conditions

Interventions

BEHAVIORAL

Community-based Stroke Awareness Program

A culturally-adapted stroke awareness and action program will be delivered by trained Stroke Promoters in the targeted neighborhoods in the south side of Chicago. Community Stroke Promoters will be trained on 1) the benefits of early recognition and EMS utilization for stroke (i.e. stroke centers, tPA), 2) culturally-adapted solutions to current barriers (i.e. misperceptions about vulnerability, severity, mistrust, costs), and 3) cues to aid in stroke recognition and immediate action. The intervention will take place at community settings throughout a 1-year period.

Sponsors & Collaborators

Principal Investigators

  • Shyam Prabhakaran, MD MS · Northwestern University

  • Neelum T Aggarwal, MD · Rush University Medical Center

  • Knitasha Washington, DHA FACHE · Washington Howard and Associates

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2018-05-31
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02301299 on ClinicalTrials.gov